André-Pascal Sappino

The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage

W. Reith, S. Mandriota, F. Gumy-Pause, 2012, Oncogenesis.

Open Peer Review Invited Referee Responses Case Report: Expanding the Tumour Spectrum Associated with the Birt-hogg-dubé Cancer Susceptibility Syndrome [v1; Ref Status

J. Lamoril, E. Longchampt, C. Massard, 2022 .

Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.

D. Belin, A. Sappino, J. Vassalli, 1991, The Journal of clinical investigation.

ATM gene and lymphoid malignancies

F. Gumy-Pause, A. Sappino, P. Wacker, 2004, Leukemia.

Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study.

A. Desmoulière, G. Gabbiani, A. Sappino, 1994, Plastic and reconstructive surgery.

Plasminogen activation in melanocytic neoplasia.

André-Pascal Sappino, J. Saurat, Jean-Dominique Vassalli, 1994, Cancer research.

Plasminogen activation in human acute leukaemias

A. Sappino, J. Vassalli, E. Kruithof, 1999, British journal of haematology.

Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

D. Belin, A. Sappino, J. Vassalli, 1996, The Journal of clinical investigation.

Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.

M. Escher, A. Sappino, André-Pascal Sappino, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Plasmin-catalyzed proteolysis in colorectal neoplasia.

A. Sappino, J. Vassalli, C. Delbaldo, 1995, Cancer research.